← Evidence map

ArticleCancer medicine journal2023

ANK Therapeutic Prospects and Usefulness of PD-L1 and NK Activity as Biomarkers for Predicting Treatment Efficacy Revealed from the Treatment Course of Patients with HTLV-1-Associated Bronchioloalveolar Disease.

Kenjiro Nagai et al.PubMed ↗Full text ↗

No numbers read from the abstract.

1 paper cites it

2023

this papercites it

ANK Therapeutic Prospects and Usefulness of PD-L1 and NK Activity as Biomarkers for Predicting Treatment Efficacy Revealed from the Treatment Course of Patients with HTLV-1-Associated Bronchioloalveolar Disease. | OpenQuestion